Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chylothorax].

J Norum1, E Wist, U Aasebø

  • 1Kreftavdelingen, Regionsykehuset i Tromsøo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|September 30, 1990
PubMed
Summary
This summary is machine-generated.

Chylothorax, a rare condition involving lymphatic fluid in the chest, can stem from non-Hodgkin lymphoma. Treatment often combines surgery, radiation, and sclerosing agents for effective management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?

International journal of circumpolar health·2017
Same author

Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013.

International journal of cancer·2017
Same author

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.

British journal of cancer·2013
Same author

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.

British journal of cancer·2012
Same author

Delay in diagnosis and treatment of breast cancer in northern Norway.

Oncology reports·2011
Same author

Radiotherapy costs in glioblastoma.

Oncology reports·2011
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Area of Science:

  • Oncology
  • Thoracic Medicine
  • Medical Research

Background:

  • Chylothorax is a rare condition characterized by the accumulation of lymphatic fluid in the pleural space.
  • Common etiologies include trauma, malignancy, and idiopathic causes.
  • Non-Hodgkin lymphoma is an increasingly recognized cause of chylothorax.

Observation:

  • A 51-year-old male patient presented with chylothorax.
  • The patient's chylothorax was attributed to abdominal non-Hodgkin lymphoma.
  • This case highlights the link between hematologic malignancies and thoracic complications.

Findings:

  • The patient's chylothorax was successfully managed through a multimodal treatment approach.
  • Treatment involved a combination of surgical intervention, conservative measures, high-voltage radiation, and pleurodesis.

Related Experiment Videos

  • This illustrates the complexity of treating chylothorax secondary to malignancy.

    • Implications:

    • Early recognition of chylothorax in lymphoma patients is crucial for timely intervention.
    • Multidisciplinary management is key to improving outcomes for chylothorax patients.
    • Further research into the pathogenesis and optimal treatment strategies for malignancy-associated chylothorax is warranted.